After finishing at $4.72 in the prior trading day, Eastman Kodak Co. (NYSE: KODK) closed at $4.54, down -3.81%. On the day, 742355 shares were traded.
Ratios:
Our goal is to gain a better understanding of KODK by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.46. For the most recent quarter (mrq), Quick Ratio is recorded 1.75 and its Current Ratio is at 2.52. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.42.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 16 ’23 when Katz Philippe D bought 6,000 shares for $3.70 per share. The transaction valued at 22,200 led to the insider holds 161,496 shares of the business.
Katz Philippe D bought 3,000 shares of KODK for $13,770 on May 22 ’23. The Director now owns 155,496 shares after completing the transaction at $4.59 per share. On May 19 ’23, another insider, SILECK MICHAEL, who serves as the Director of the company, bought 15,000 shares for $4.39 each. As a result, the insider paid 65,850 and bolstered with 74,575 shares of the company.
Valuation Measures:
As of this moment, Eastman’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.32 while its Price-to-Book (P/B) ratio in mrq is 0.39.
Stock Price History:
Over the past 52 weeks, KODK has reached a high of $6.34, while it has fallen to a 52-week low of $3.17.
Shares Statistics:
A total of 79.60M shares are outstanding, with a floating share count of 62.27M. Insiders hold about 22.06% of the company’s shares, while institutions hold 45.64% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Eastman Kodak Company different market analysts. The consensus estimate for the next quarter is $3.87, with high estimates of $0.01 and low estimates of $14.66.
Analysts are recommending an EPS of between $Healthcare and $Financial Services for the fiscal current year, implying an average EPS of $Healthcare.
